Concurrent Investment Advisors, LLC Ice Cure Medical Ltd. Transaction History
Concurrent Investment Advisors, LLC
- $3.39 Trillion
- Q3 2024
A detailed history of Concurrent Investment Advisors, LLC transactions in Ice Cure Medical Ltd. stock. As of the latest transaction made, Concurrent Investment Advisors, LLC holds 10,000 shares of ICCM stock, worth $11,200. This represents 0.0% of its overall portfolio holdings.
Number of Shares
10,000
Previous 10,000
-0.0%
Holding current value
$11,200
Previous $7.4 Million
17.57%
% of portfolio
0.0%
Previous 0.0%
Shares
1 transactions
Others Institutions Holding ICCM
# of Institutions
16Shares Held
195KCall Options Held
0Put Options Held
0-
Ubs Group Ag59.9KShares$67,0810.0% of portfolio
-
Xtx Topco LTD London, X026.3KShares$29,4680.0% of portfolio
-
Geode Capital Management, LLC Boston, MA25.6KShares$28,6270.0% of portfolio
-
Two Sigma Investments, LP New York, NY18.5KShares$20,7480.0% of portfolio
-
Virtu Financial LLC New York, NY14.6KShares$16,3260.0% of portfolio
About IceCure Medical Ltd.
- Ticker ICCM
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 36,835,600
- Market Cap $41.3M
- Description
- IceCure Medical Ltd, a medical device company, engages in the research, development, and commercialization of medical devices for cryoablation (freezing) of tumors in the human body. It offers ProSense system, a cryoablation solution for the treatment of breast tumors. The company was incorporated in 2006 and is headquartered in Caesarea, Israel.